首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1489203

全球可生物降解支架市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Biodegradable Stents Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年05月01日 | 出版商:

Value Market Research | 英文 167 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球生物降解支架市场需求预计将从2023年的3.5356亿美元达到近7.1387亿美元的市场规模，2024-2032年研究期间复合年增长率为8.12%。

可生物降解支架是用于治疗冠状动脉疾病 (CAD) 和周边动脉疾病 (PAD) 等动脉狭窄或阻塞的医疗器材。与永久植入体内的传统金属支架不同，这些支架的设计会随着时间的推移逐渐降解并被身体吸收。这种创新方法降低了与永久植入物相关的长期併发症的风险，例如再狭窄和血栓形成。这些支架促进自然血管癒合和动脉功能恢復，同时最大限度地减少长期抗血小板治疗的需要。它们为需要血管介入治疗的患者提供了一个有前景的解决方案，提供有效的治疗，降低长期风险并改善临床结果。

市场动态

全球冠状动脉疾病 (CAD) 和周边动脉疾病 (PAD) 的流行，加上对微创治疗的需求不断增加，正在推动可生物降解支架作为传统金属支架的替代品。随着患者和医疗保健提供者寻求更安全、更有效的解决方案来恢復血流和防止动脉阻塞，这些支架具有多种优势，包括降低再狭窄风险、改善长期结果和增强血管癒合。此外，支架设计、生物相容性材料和药物洗脱技术的进步正在推动市场创新，从而能够开发出具有更高灵活性、可输送性和药物释放动力学的设备，以优化临床结果。

此外，生物可降解支架在复杂病变、分叉和高风险患者群体中的不断扩大应用正在推动市场成长和多样化。此外，医疗保健领域对永续性和环境管理的日益重视推动了对可生物降解支架的需求，这些支架最大限度地减少了对长期异物植入的需求并降低了晚期併发症的风险，从而推动了市场扩张。然而，替代支架材料和设计的开发以及介入性心臟病学技术的进步可能会挑战未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球可生物降解支架市场的各个细分市场进行了包容性评估。可生物降解支架产业的成长和趋势为本研究提供了整体方法。

市场区隔

可生物降解支架市场报告的这一部分提供了有关国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按支架类型

冠状动脉支架
週边动脉支架

依材料类型

聚合物基
金属基

按最终用户

医院
心导管实验室
门诊手术中心

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的可生物降解支架市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。可生物降解支架市场的主要参与者包括波士顿科学公司、雅培、Elixir Medical Corporation、Kyoto Medical Planning Co. Ltd.、Biotronik、Terumo Corporation、Biosensors International Group、ELLA - CS SRO、SMT。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：生物可降解支架公司的竞争格局

生物可降解支架市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
Boston Scientific Inc.

公司简介
公司收入
产品
最近的发展

Abbott

公司简介
公司收入
产品
最近的发展

Elixir Medical Corporation

公司简介
公司收入
产品
最近的发展

Kyoto Medical Planning Co. Ltd.

公司简介
公司收入
产品
最近的发展

Biotronik

公司简介
公司收入
产品
最近的发展

Terumo Corporation

公司简介
公司收入
产品
最近的发展

Biosensors International Group

公司简介
公司收入
产品
最近的发展

ELLA - CS SRO

公司简介
公司收入
产品
最近的发展

公司简介
公司收入
产品
最近的发展

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR112114534

The global demand for Biodegradable Stents Market is presumed to reach the market size of nearly USD 713.87 Million by 2032 from USD 353.56 Million in 2023 with a CAGR of 8.12% under the study period 2024-2032.

Biodegradable stents are medical devices used to treat narrowed or blocked arteries in conditions such as coronary artery disease (CAD) & peripheral artery disease (PAD). Unlike traditional metal stents, which remain permanently implanted in the body, these stents are designed to degrade and be absorbed by the body gradually over time. This innovative approach reduces the risk of long-term complications associated with permanent implants, such as restenosis and thrombosis. These stents promote natural vessel healing and restoration of arterial function while minimizing the need for long-term antiplatelet therapy. They offer a promising solution for patients requiring vascular interventions, providing effective treatment with reduced long-term risks and improved clinical outcomes.

MARKET DYNAMICS

The spurring prevalence of coronary artery disease (CAD) and peripheral artery disease (PAD) worldwide, coupled with the escalating demand for minimally invasive treatments, is driving the adoption of biodegradable stents as alternatives to traditional metal stents. As patients & healthcare providers seek safer and more effective solutions for restoring blood flow and preventing artery blockages, these stents offer several advantages, including reduced risk of restenosis, improved long-term outcomes, and enhanced vascular healing. Additionally, advancements in stent design, biocompatible materials, and drug-eluting technologies are driving innovation in the market, enabling the development of devices with improved flexibility, deliverability, and drug release kinetics to optimize clinical outcomes.

Furthermore, the expanding applications of biodegradable stents in complex lesions, bifurcations, and high-risk patient populations are driving market growth and diversification. Moreover, the rising emphasis on sustainability & environmental stewardship in healthcare drives demand for biodegradable stents that minimize the need for long-term foreign body implants and reduce the risk of late complications, driving market expansion. However, the development of alternative stent materials and designs and advancements in interventional cardiology techniques may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Biodegradable Stents. The growth and trends of Biodegradable Stents industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Biodegradable Stents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Stent Type

Coronary Artery Stents
Peripheral Artery Stents

By Material Type

Polymer-based
Metal-based

By End-user

Hospitals
Cardiac Catheterization Laboratories
Ambulatory Surgery Centers

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Biodegradable Stents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Biodegradable Stents market include Boston Scientific Inc., Abbott, Elixir Medical Corporation, Kyoto Medical Planning Co. Ltd., Biotronik, Terumo Corporation, Biosensors International Group, ELLA - CS S.R.O., SMT. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. BIODEGRADABLE STENTS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Stent Type
- 3.7.2 Market Attractiveness Analysis By Material Type
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIODEGRADABLE STENTS MARKET ANALYSIS BY STENT TYPE

5.1. Overview By Stent Type
5.2. Historical and Forecast Data
5.3. Analysis By Stent Type
5.4. Coronary Artery Stents Historic and Forecast Sales By Regions
5.5. Peripheral Artery Stents Historic and Forecast Sales By Regions

6. GLOBAL BIODEGRADABLE STENTS MARKET ANALYSIS BY MATERIAL TYPE

6.1. Overview By Material Type
6.2. Historical and Forecast Data
6.3. Analysis By Material Type
6.4. Polymer-based Historic and Forecast Sales By Regions
6.5. Metal-based Historic and Forecast Sales By Regions

7. GLOBAL BIODEGRADABLE STENTS MARKET ANALYSIS BY END-USER

7.1. Overview By End-user
7.2. Historical and Forecast Data
7.3. Analysis By End-user
7.4. Hospitals Historic and Forecast Sales By Regions
7.5. Cardiac Catheterization Laboratories Historic and Forecast Sales By Regions
7.6. Ambulatory Surgery Centers Historic and Forecast Sales By Regions

8. GLOBAL BIODEGRADABLE STENTS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BIODEGRADABLE STENTS COMPANIES

9.1. Biodegradable Stents Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF BIODEGRADABLE STENTS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Boston Scientific Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Abbott
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Elixir Medical Corporation
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Kyoto Medical Planning Co. Ltd.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Biotronik
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Terumo Corporation
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Biosensors International Group
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. ELLA - CS S.R.O.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. SMT
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments